| Dr Kenneth J Shulman, MD | |
|
100 Midland Ave, Port Chester, NY 10573-4943 | |
| (800) 942-3376 | |
| (914) 934-9819 |
| Full Name | Dr Kenneth J Shulman |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 27 Years |
| Location | 100 Midland Ave, Port Chester, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215916762 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 2030431 (New York) | Secondary |
| 207ZD0900X | Pathology - Dermatopathology | 2030431 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Metropolitan Hospital Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metropolitan Medical Practice Plan Pc | 8022286384 | 202 |
| Connecticut Skinhealth Llp | 9638309362 | 28 |
News Archive
Australian scientists have shown how a 'transcription factor' causes breast cancer to develop an aggressive subtype that lacks sensitivity to oestrogen and does not respond to anti-oestrogen therapies such as Tamoxifen and aromatase inhibitors.
Losing an arm doesn't have to mean losing all sense of touch, thanks to prosthetic arms that stimulate nerves with mild electrical feedback.
Suffering from end-stage renal disease (ESRD), a growing number of patients at the Centre hospitalier de l'Université de Montréal (CHUM), have become the beneficiaries of a North American breakthrough: high efficacy hemodiafiltration (HDF).
A team of researchers from the Research Institute of the McGill University Health Center found that elevations in a unusual form of cholesterol, called Lipoprotein(a) or Lp(a), as responsible for 1 in 14 heart attacks and 1 in 7 cases of aortic valve disease.
› Verified 1 days ago
| Entity Name | Metropolitan Medical Practice Plan Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306138383 PECOS PAC ID: 8022286384 Enrollment ID: O20110713000171 |
News Archive
Australian scientists have shown how a 'transcription factor' causes breast cancer to develop an aggressive subtype that lacks sensitivity to oestrogen and does not respond to anti-oestrogen therapies such as Tamoxifen and aromatase inhibitors.
Losing an arm doesn't have to mean losing all sense of touch, thanks to prosthetic arms that stimulate nerves with mild electrical feedback.
Suffering from end-stage renal disease (ESRD), a growing number of patients at the Centre hospitalier de l'Université de Montréal (CHUM), have become the beneficiaries of a North American breakthrough: high efficacy hemodiafiltration (HDF).
A team of researchers from the Research Institute of the McGill University Health Center found that elevations in a unusual form of cholesterol, called Lipoprotein(a) or Lp(a), as responsible for 1 in 14 heart attacks and 1 in 7 cases of aortic valve disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth J Shulman, MD 14275 Midway Rd, Suite 400, Addison, TX 75001-3614 Ph: (214) 932-8029 | Dr Kenneth J Shulman, MD 100 Midland Ave, Port Chester, NY 10573-4943 Ph: (800) 942-3376 |
News Archive
Australian scientists have shown how a 'transcription factor' causes breast cancer to develop an aggressive subtype that lacks sensitivity to oestrogen and does not respond to anti-oestrogen therapies such as Tamoxifen and aromatase inhibitors.
Losing an arm doesn't have to mean losing all sense of touch, thanks to prosthetic arms that stimulate nerves with mild electrical feedback.
Suffering from end-stage renal disease (ESRD), a growing number of patients at the Centre hospitalier de l'Université de Montréal (CHUM), have become the beneficiaries of a North American breakthrough: high efficacy hemodiafiltration (HDF).
A team of researchers from the Research Institute of the McGill University Health Center found that elevations in a unusual form of cholesterol, called Lipoprotein(a) or Lp(a), as responsible for 1 in 14 heart attacks and 1 in 7 cases of aortic valve disease.
› Verified 1 days ago
Dr. Howard B Goldstein, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 Midland Ave, Port Chester, NY 10573 Phone: 914-636-0136 Fax: 914-636-5075 | |
Dr. Naghmeh Yousefzadeh, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 Midland Ave, Port Chester, NY 10573 Phone: 914-934-5836 Fax: 914-934-9819 | |
Dr. Alan J Halperin, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 Midland Ave, Port Chester, NY 10573 Phone: 800-942-3376 Fax: 914-934-9819 | |
Dr. Damian P Dicostanzo, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 Midland Ave, Port Chester, NY 10573 Phone: 800-942-3376 Fax: 914-934-9819 | |
Patrick S Brunhoeber, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 Midland Ave, Port Chester, NY 10573 Phone: 800-942-3376 Fax: 914-934-9819 | |
Marie C Sicari, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 Midland Ave, Port Chester, NY 10573 Phone: 914-934-9739 Fax: 914-934-9819 |